Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05788016
NA

Developing an Opioid Taper Intervention Before Total Joint Arthroplasty

Sponsor: University of Alabama at Birmingham

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to develop an pharmacist-led preoperative opioid taper intervention for patients undergoing total knee or hip replacement who are on chronic opioids before their surgery. The main questions it aims to answer are: * Is the intervention feasible and acceptable to patients? * Does the intervention result in a decrease in opioid dose during the preoperative period? Participants will meet with a clinical pharmacist, who will provide some basic education on pain and opioids, and will propose an opioid taper schedule. The pharmacist will then follow-up with the participant by phone each week until surgery to assess progress and adjust the taper as necessary.

Official title: Developing and Testing an Opioid Taper Intervention Before Total Knee Arthroplasty: Phase 2 Intervention Development

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2024-01-10

Completion Date

2027-07-01

Last Updated

2026-10-22

Healthy Volunteers

No

Interventions

BEHAVIORAL

opioid taper

The participant will attempt to taper their opioid dose by \~50% during the 4-6 week preoperative period

Locations (1)

UAB Hospital-Highlands

Birmingham, Alabama, United States